Treatment Outcomes for Right-Sided Endocarditis in Intravenous Drug Users: A Systematic Review and Analysis of Outcomes in a Tertiary Centre
09 November 2017
03 December 2017
19 January 2018 (online)
Background The increasing prevalence of intravenous drug users (IVDU) has resulted in higher incidence of right-sided infective endocarditis (RSIE). However, treatment guidelines for RSIE in IVDU are not well defined. The aim is to evaluate efficacy of different treatment strategies in reducing mortality and to describe treatment outcomes.
Methods We systematically reviewed the literature using PubMed, Cochrane, CENTRAL, OvidEMBASE, Web of Science, and Medline databases to include prospective studies that compare mortality rates among IVDU with RSIE receiving isolated medical treatment versus those receiving medical–surgical treatment. In conjunction, analysis of 27 RSIE patients (including IVDU) treated at authors' institution was done to supplement the findings. Kaplan–Meier survival rates following hospital admission and cumulative incidence estimates for hospital re-admission were obtained.
Results A total of nine studies (all with low or marginal risk of bias) met inclusion criteria. The prevalence of RSIE among IVDU with infective endocarditis varied from 34% to 100%. Seven studies compared medical versus medical–surgical therapy with less than 30% needing surgery. Mortality was higher in patients receiving surgical therapy. There were 27 RSIE (16 non-IVDU and 11 IVDU) analyzed at the authors' institution. Survival at 30 days, 1 year, and 3 years were 89%, 82%, and 78%, respectively, and repeat hospitalization for recurrent endocarditis were 8%, 17%, and 23%, respectively.
Conclusions There is paucity around optimal RSIE management strategy for IVDU that can decrease mortality. Surgical management of RSIE may be associated with increased mortality over medical management mainly due to advanced surgical indications.
- 1 Bin Abdulhak AA, Baddour LM, Erwin PJ. , et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart 2014; 9 (01) 131-143
- 2 Yuan SM. Right-sided infective endocarditis: recent epidemiologic changes. Int J Clin Exp Med 2014; 7 (01) 199-218
- 3 Ruotsalainen E, Sammalkorpi K, Laine J. , et al. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis 2006; 6: 137 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med5&NEWS=N&AN=16965625
- 4 Roberts WC, Buchbinder NA. Right-sided valvular infective endocarditis. A clinicopathologic study of twelve necropsy patients. Am J Med 1972; 53 (01) 7-19
- 5 Cooper HLF, Brady JE, Ciccarone D, Tempalski B, Gostnell K, Friedman SR. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis 2007; 45 (09) 1200-1203
- 6 Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003; 89 (05) 577-581
- 7 Gaca JG, Sheng S, Daneshmand M. , et al. Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg 2013; 96 (04) 1374-1381
- 8 Shetty N, Nagpal D, Koivu S, Mrkobrada M. Surgical and medical management of isolated tricuspid valve infective endocarditis in intravenous drug users. J Card Surg 2016; 31 (02) 83-88 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=medl&NEWS=N&AN=26687478
- 9 Anantha Narayanan M, Mahfood Haddad T, Kalil AC. , et al. Early versus late surgical intervention or medical management for infective endocarditis: a systematic review and meta-analysis. Heart 2016; 102 (12) 950-957
- 10 Liberati A, Altman DG, Tetzlaff J. , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62 (10) e1-e34
- 11 Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. . (2015). The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Ottawa Hospital Research Institute, 2014.
- 12 Dettori JR. Loss to follow-up. Evid Based Spine Care J 2011; 2 (01) 7-10
- 13 Statistics Canada. Life tables, Canada, provinces and territories 2009 to 2011. Available at: http://www.statcan.gc.ca/pub/84-537-x/84-537-x2013005-eng.htm . Accessed August 24, 2017
- 14 Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992; 117 (07) 560-566
- 15 Delahaye F, Goulet V, Lacassin F. , et al. Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J 1995; 16 (03) 394-401 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed6&NEWS=N&AN=25106625
- 16 Sani AT, Mojtabavi M, Bolandnazar R. Effect of vegetation size on the outcome of infective endocarditis in intravenous drug users. Iran J Clin Infect Dis 2009; 4 (03) 129-134 http://www.idtmrc.ac.ir/Journal/ijcid.aspxhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=358244998
- 17 Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996; 22 (02) 276-286
- 18 Martín-Dávila P, Navas E, Fortún J. , et al. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size. Am Heart J 2005; 150 (05) 1099-1106
- 19 Hubbell G, Cheitlin MD, Rapaport E. Presentation, management, and follow-up evaluation of infective endocarditis in drug addicts. Am Heart J 1981; 102 (01) 85-94 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed2&NEWS=N&AN=11086994
- 20 Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995; 155 (15) 1641-1648 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med3&NEWS=N&AN=7618988
- 21 Ortiz C, López J, García H. , et al. Clinical classification and prognosis of isolated right-sided infective endocarditis. Medicine (Baltimore) 2014; 93 (27) e137
- 22 Tanriover B, Carlton D, Saddekni S. , et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000; 57 (05) 2151-2155
- 23 Kang D-H, Kim Y-J, Kim S-H. , et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012; 366 (26) 2466-2473
- 24 García-Cabrera E, Fernández-Hidalgo N, Almirante B. , et al; Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases; Spanish Network for Research in Infectious Diseases. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013; 127 (23) 2272-2284
- 25 Farrington DK, Kilgo PD, Thourani VH, Jacob JT, Steinberg JP. High risk of prosthetic valve endocarditis and death after valve replacement operations in dialysis patients. Ann Thorac Surg 2016; 101 (06) 2217-2223